While Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its ...

Company behind weight loss drug Mounjaro, Lilly, has issued an official statement after British woman, Susan McGowan, died ...

Analysts cited data from a phase one study showing the highest dose of Amgen’s MariTide was linked to roughly 4% loss of bone ...

SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...

Novo Nordisk is working on a new obesity drug that could help patients shed more than any other weight-loss drug on the ...

SAN ANTONIO — Oral semaglutide 25 mg appears to be just as effective in promoting weight loss and other beneficial outcomes ...

Conditions are getting a bit more challenging for the drugmaker.

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO), the kings of the titanic weight-loss drugs market, might have a problem on their hands. After reporting their third-quarter earnings, shares of both ...

A small player like Viking may also win by attracting a partner or even a company that will offer to acquire the biotech.

Novo Nordisk reported earnings, posting some chunky year-over-year growth and far outperforming its only real rival at the ...